Lazard Asset Management
SEM

Lazard Asset Management’s Select Medical SEM Stock Holding History

Lazard Asset Management’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,315
Closed -$104K – 2510
2025
Q1 		$104K Sell
6,315
-659
-9% -$12.1K ﹤0.01% 1799
2024
Q4 		$130K Sell
6,974
-1,784
-20% -$34.4K ﹤0.01% 1729
2024
Q3 		$162K Buy
8,758
+105
+1% +$2.01K ﹤0.01% 1660
2024
Q2 		$163K Buy
+8,653
New +$148K ﹤0.01% 1622
2022
Q4 		– Sell
-2,602
Closed -$30K – 2548
2022
Q3 		$30K Sell
2,602
-3,582
-58% -$50.9K ﹤0.01% 1984
2022
Q2 		$78K Buy
6,184
+2,270
+58% +$29.1K ﹤0.01% 1611
2022
Q1 		$50K Hold
3,914
– – ﹤0.01% 1741
2021
Q4 		$62K Sell
3,914
-68,620
-95% -$1.17M ﹤0.01% 1643
2021
Q3 		$1.41M Sell
72,534
-418,890
-85% -$8.32M ﹤0.01% 980
2021
Q2 		$11.2M Sell
491,424
-15,650
-3% -$325K 0.01% 573
2021
Q1 		$9.32M Buy
507,074
+502,623
+11,292% +$8.24M 0.01% 567
2020
Q4 		$66K Buy
4,451
+654
+17% +$8.54K ﹤0.01% 1303
2020
Q3 		$42K Sell
3,797
-3,595
-49% -$35.4K ﹤0.01% 1236
2020
Q2 		$58K Sell
7,392
-99,775
-93% -$827K ﹤0.01% 1194
2020
Q1 		$866K Buy
107,167
+103,962
+3,244% +$1.24M ﹤0.01% 758
2019
Q4 		$40K Buy
+3,205
New +$34.5K ﹤0.01% 1105
2019
Q3 		– Sell
-74,530
Closed -$637K – 1559
2019
Q2 		$637K Buy
+74,530
New +$589K ﹤0.01% 909
2016
Q3 		– Sell
-179,202
Closed -$1.05M – 1042
2016
Q2 		$1.05M Buy
+179,202
New +$1.19M ﹤0.01% 683
2015
Q2 		– Sell
-1,221
Closed -$9K – 1174
2015
Q1 		$9K Buy
+1,221
New +$9.12K ﹤0.01% 1061

Other funds holding SEM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
8KM
8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Lazard Asset Management's SEM Position: Q2 2025 in Review

Lazard Asset Management sold out of Select Medical (SEM) in Q2 2025, closing a stake of 6,315 shares — an estimated $104K sold.

Lazard Asset Management first reported a position in SEM in Q1 2015 and held it in 19 quarters. The position peaked at $11.2M in Q2 2021. 262 funds tracked by Wall St. Rank hold SEM as of Q2 2025.

  • Lazard Asset Management reported no remaining Select Medical position as of Q2 2025 after selling out during the quarter.
  • Lazard Asset Management sold 6,315 Select Medical shares in Q2 2025, an estimated $104K.
  • Lazard Asset Management first reported a position in Select Medical in Q1 2015 and held it in 19 quarters.
  • Lazard Asset Management's Select Medical position peaked at $11.2M in Q2 2021.
  • 262 funds tracked by Wall St. Rank held Select Medical as of Q2 2025.

Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.